| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ms6646-12 | Grouping:Control | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-17 | Grouping:Control | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-22 | Grouping:Control | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-4 | Grouping:Control | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-5 | Grouping:Control | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-10 | Grouping:Control | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-20 | Grouping:Control | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-25 | Grouping:Control | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-6 | Grouping:Control | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-9 | Grouping:Control | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-15 | Grouping:Weight Losing | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-18 | Grouping:Weight Losing | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-19 | Grouping:Weight Losing | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-2 | Grouping:Weight Losing | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-28 | Grouping:Weight Losing | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-1 | Grouping:Weight Losing | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-14 | Grouping:Weight Losing | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-21 | Grouping:Weight Losing | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-24 | Grouping:Weight Losing | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-27 | Grouping:Weight Losing | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-13 | Grouping:Weight Stable | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-26 | Grouping:Weight Stable | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-29 | Grouping:Weight Stable | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-3 | Grouping:Weight Stable | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-8 | Grouping:Weight Stable | Gender:Female | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-11 | Grouping:Weight Stable | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-16 | Grouping:Weight Stable | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-23 | Grouping:Weight Stable | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-30 | Grouping:Weight Stable | Gender:Male | ug/vial |
| Reversed phase POSITIVE ION MODE | ms6646-7 | Grouping:Weight Stable | Gender:Male | ug/vial |
Return to study ST001016 main page
Download data matrix(Sphingolipid Concentrations in Muscle Tissue of Muscle Wasting in Cancer Cachexia (part-III) Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|